Abstract. Kupffer cells (KCs) influence liver allografts by interacting with other non-parenchymal cells. However, the exact mechanism remains unclear. Upregulation of heme oxygenase-1 (HO-1) in KCs upon interaction with mast cells (MCs), and the effects on dendritic cell (DC) function, were investigated in the present study. KCs, MCs and DCs were prepared from 8-10-week-old C57BL/6 mice. KCs were pretreated with PBS, dimethyl sulfoxide, hemin (50 µM; HO-1 inducer), and zinc protoporphyrin (50 µM; HO-1 inhibitor) for 8 h. Reverse transcription-polymerase chain reaction and western blotting was performed to determine HO-1 mRNA and protein levels in KCs, respectively. C-C motif chemokine receptor 7 (CCR7) surface molecules were measured using flow cytometry, and prostaglandin E2 (PGE2), C-C motif chemokine ligand (CCL) 19 and CCL21 were measured by ELISA. The Transwell model was used to investigate the migration of DCs. Pretreatment of KCs with hemin induced HO-1 transcription and protein expression, and interacted with and stabilized MC membranes. When co-cultured with MCs, the expression of CCR7 on DCs was reduced, and PGE2, CCL19 and CCL21 were similarly decreased. DC migration was also impaired. Upregulation of HO-1 in KCs blocked MC degranulation and reduced DC migration.
Introduction
Heme oxygenase-1 (HO-1) has an important protective role in various disease models due to its anti-inflammatory, anti-apoptotic and anti-proliferative actions (1, 2) . HO-1 also has an important role in the allograft immune response. Following liver transplantation, various cell types induce HO-1 overexpression to prevent ischemia reperfusion injury (IRI) and immune rejection (3) (4) (5) . It is well established that Kupffer cells (KCs) are among the most important resident macrophages of the liver and account for ~20% of all hepatic non-parenchymal cells (6) . Increased attention has focused on the potential roles and mechanisms of KCs in tolerance induction following liver allografts. Wang et al (7) demonstrated that preconditioning with nodosin perfusion induced HO-1 expression in KCs following transplantation, and this upregulation was demonstrated to be protective against IRI, a process which is thought to facilitate immune rejection.
It is now appreciated that the function of mast cells (MCs) is not limited to allergic disease or chronic immune rejection. Recent studies have reported that active MCs degranulate to induce IRI and acute immune rejection (8, 9) , and these cells influence the tissue microenvironment via release of a variety of pre-existing and cell-synthesized mediators, including proteases, cytokines, chemokines and arachidonic acid metabolites (10) . A previous study reported that MC degranulation may disrupt peripheral immune tolerance and result in immune rejection (11) , and also suggests that MC degranulation may promote IRI in the rat liver (12) . Stabilizing MC membranes may, therefore, alleviate immune rejection and IRI. Takamiya et al (13) demonstrated that HO-1 stabilizes MCs following exposure to the anti-inflammatory compound bilirubin.
Dendritic cells (DCs) are one of the most potent types of antigen-presenting cells and are known to be important in triggering immunity to various types of antigens (14) . Under normal circumstances, DCs are immature in vivo, and co-stimulation of CD80, CD86 and major histocompatibility complex class II at the surface of DCs is low (15 Cell preparation. C57/BL6 mice were sacrificed by anesthesia with intraperitoneal injection of ketamine (9 0 mg / kg) (Sig m a-A ld r ich; Me r ck M i l l ip or e) and xylazine (10 mg/ kg) (Sigma-Aldr ich; Merck Millipore) solution and test for loss of ref lexes to ensure deep narcotization. Then, non-parenchymal cell suspensions were acquired from C57/BL6 mice using in situ collagenase perfusion of liver and KCs were isolated by sedimentation in a two-step Percoll gradient with selective adherence of cells to plastic flasks as previously described (3). Cell viability was determined by trypan blue exclusion, and the purity of the KC fraction was determined using anti-mouse F4/80-APC (dilution 1:20) and anti-mouse CD11b-FITC antibodies (dilution 1:40). Murine bone marrow-derived mast cells (BMMCs) and DCs (BMDCs) were obtained as described previously (17, 18) . The cells were collected 8x10 5 and centrifuged at 135 x g 5 min at 4˚C, then the cells were resuspended in PBS and 2% fetal bovine serum 200 µl. All cells were incubated with the antibody for 30 min on ice, then washed twice with PBS and 2% serum and centrifuged at 1,200 x g for 5 min, analysis was performed using FlowJo 7.6. The purity of BMMCs was assessed by measuring the expression of CD117 and FCεRIα using flow cytometry. BMMCs were used at a purity of 95%. The purity of DCs was analyzed by measuring CD11c expression using flow cytometry.
RT-PCR and RT-qPCR. Total RNA was isolated from KCs using TRIzol (Sigma-Aldrich; Merck Millipore) according to standard procedures. Thereafter, 2 µg of total RNA was reverse transcribed to cDNA using the Superscript III Transcription kit (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) with Genomic DNA Eraser (Takara Biotechnology Co., Ltd., Dalian, China) according to manufacturer's protocol. PCR was performed on a Px2 Thermal Cycler, using the following conditions: 1 cycle of denaturation at 95˚C for 5 min, 35 cycles of denaturation at 94˚C for 30 sec, annealing at 55˚C for 30 sec, and extension at 72˚C for 40 sec and an additional cycle of extension at 72˚C for 10 min. Then 2% gel was used. GAPDH was used as an internal control. qPCR was performed on a Chromo4 Four-Color Real-Time PCR Detection system (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using the SYBR Premix Ex Taq II (Tli RNaseH Plus) kit (Takara Biotechnology Co., Ltd.). Using the following conditions: Initial the cycle of denaturation at 95˚C for 30 sec, followed by 40 cycles of 95˚C for 5 sec, annealing 60˚C for 30 sec and extension 70˚C for 15 sec. Data was normalized using the 2 -ΔΔCq method (19) . PCR was performed on an ABI Prism 7700 (Applied Biosystems; Thermo Fisher Scientific, Inc.). Protein extraction and western blotting. Reagents were purchased from Sigma-Aldrich unless otherwise indicated. Proteins were extracted from KCs and western blotting was performed. Briefly, 2.5-6x10 6 cells were incubated for 15 min on ice in lysis buffer [50 mM TrisHCl pH 8.0; 120 mM NaCl; 0.25% Nonidet P40; 0.1% SDS; and protease inhibitors phenylmethylsulfonyl fluoride, aprotinin, leupeptin, and pepstatin (Roche Diagnostics) at a final concentration of 10 ng/ml, 1 mM DTT]. A total of 60 mg, of each protein sample was subjected to 15% SDS-PAGE and blotted onto a nitrocellulose membrane (GE Healthcare Life Sciences, Chalfont, UK). The protein quantification performed using a BCA kit according to the manufacturer's protocol (Sigma-Aldrich; Merck Millipore). Membranes were blocked with 5% non-fat dry milk in TBS-Tween (0.5%) 4˚C overnight and probed with either rabbit anti-mouse HO-1 monoclonal antibody (2 mg/ml; Abcam) or rabbit anti-mouse β-actin monoclonal antibody (1:2,000) followed by horseradish peroxidase-conjugated anti-rabbit IgG antibody (1:3,000; cat. no. RPN4301; GE Healthcare Life Sciences, Logan, UT, USA). Immunoreactive protein bands incubated with the enhanced chemiluminescence (ECL) reagent 30 sec according to the manufacturer's protocol using an ECL detection kit (cat. no. RPN998; GE Healthcare Life Sciences) and were visualized with image lab 4.0 software.
MC degranulation assay.
After treating KCs with PBS, dimethyl sulfoxide (DMSO), 50 µM/l hemin or 50 µM/l Znpp for 8 h, cells were collected and cultured in 24-well cell culture plates at a density of 2.5x10 5 cells per 200 µl, either with direct contact with MCs or without MCs (5x10 5 cells), separated by a Transwell chamber 0.4 µm. The 50 µM/l sodium cromoglicate was used to pretreat the MC as the stabilization control. After 24 h, each group of MCs were pre-incubated with anti-dinitrophenol (DNP)-IgE (100 ng/ml) (1:1,000, cat. no. D8406; Sigma-Aldrich; Merck Millipore) for 24 h and subsequently challenged using 100 ng/ml dinitrophenol-human serum albumin DNP-HSA. After 1 h, the cell supernatant of the co-culture system was collected. Following solubilization with 0.5% Triton X-100 in Tyrode's buffer, the enzymatic activity of β-hexosaminidase in supernatants and cell pellets was measured using p-nitrophenyl-N-acetyl-β-D-glucosaminide in 0.1 M sodium citrate, pH 4.5, at 37˚C for 60 min. The reaction was halted by addition of 0.2 M glycine (pH 10.7) and the amount of p-nitrophenol released was measured by absorbance at a wavelength of 405 nm using a spectrophotometer. The extent of degranulation was calculated as the p-nitrophenol absorbance of the supernatant/the total absorbance of the supernatant and detergent-solubilized cell pellet.
Analysis of pretreated MC-DC interaction and DC migration.
MCs were cultured with KCs in 10% serum that were pretreated with PBS, DMSO, hemin or Znpp 24 h, using 50 µM/l sodium cromoglicate to pretreat the MCs as the stabilization control, then MC degranulation was stimulated with anti-DNP-IgE associated with DNP-HSA. DC migration was assessed using Transwell assays (8 µm pore size). DCs were incubated in 10% serum in upper chambers at a density of 5x10 5 cells per well, MCs by pretreated KCs in the lower chamber. After 48 h, cells in the upper chamber were discarded and DCs that had migrated to the lower chamber harvested. Cells in the lower chamber were fixed with 10% methyl alcohol, stained with 0.1% crystal violet for 20 min, washed with double distilled H 2 O and counted under an inverted microscope, at a magnification of x200.
Additionally, DCs were cultured with stimulated MCs for 24 h in Transwell plates Supernatants were harvested from lower chamber of the co-culture system, and prostaglandin E2 (PGE2) (cat. no. H6-KA0324; eBioscience USA), C-C motif chemokine ligand 19 (CCL-19) (cat. no. RK-KOA0264; eBioscience USA) and CCL21 (cat. no. 85-88-58214-22; eBioscience USA) were quantified by ELISA (eBioscience, Inc.) according to the manufacturer's instructions. DCs were incubated with immunofluorescent CD16/31 (dilution, 3 µl for 10 6 cells) and anti-mouse CCR7 antibodies for 30 min on ice then washed twice. Flow cytometry was performed using Flow Jo 7.6 software.
Statistical analysis. All statistical analysis was carried out using SPSS 9.13 (SPSS, Inc., Chicago, IL, USA) and results are presented as the mean ± standard deviation. One-way analysis of variance along with Dunnett's post hoc test was performed to determine the statistical significance of the data. P<0.05 was considered to indicate a statistically significant difference.
Results

Hemin induces HO-1 mRNA and protein expression in KCs.
HO-1 mRNA and protein levels in KCs cultured with PBS, DMSO, hemin or Znpp were measured by RT-PCR, RT-qPCR and western blotting. HO-1 mRNA was significantly increased 8 h after exposure to hemin compared with incubation with PBS, DMSO or Znpp (Fig. 1) . Consistent with these results, western blot analysis demonstrated that HO-1 protein levels were lower in PBS, DMSO and Znpp-treated groups after 8 h, compared with the hemin-treated group (Fig. 2) .
Upregulation of HO-1 expression in KCs may inhibit mast cell degranulation. KCs were pretreated with PBS, DMSO, hemin or Znpp for 8 h and cultured either in contact with
MCs or separately (Fig. 3) . After 24 h, MC degranulation was stimulated with anti-DNP-IgE and DNP-HSA, and enzymatic activity of β-hexosaminidase was used to estimate the level of MC degranulation usually. Following treatment with hemin, a decrease in β-hexosaminidase release was observed in KCs that were in contact with MCs, and also those that were separate from MCs. There was no difference between the sodium cromoglicate group and hemin group demonstrating that upregulation of HO-1 in KCs may inhibit MC degranulation and stabilize MC membranes.
MC degranulation stimulates CCR7 expression on the DC surface, and stabilizing the MC membrane diminishes CCR7 expression. DC migration from peripheral tissues to secondary immune organs, particularly lymph nodes, is a prerequisite for initiating an effective immune response, and CCR7 expression at the surface of DCs facilitates homing (20, 21) . MC membranes were stabilized by hemin-pretreated KCs, whether cultured in contact or separately as mentioned above, therefore MCs cultured separately were selected for use in further experiments. Degranulation was stimulated and they were co-cultured with DCs. After 24 h, expression of CCR7 at the DC surface was decreased in hemin and sodium cromoglicate-treated groups compared with PBS, DMSO and Znpp-treated groups (Fig. 4) , and there was no difference between the sodium cromoglicate group and hemin group.
MC degranulation stimulates DC migration.
Transwell plates were used to investigate DC migration (Fig. 5) , and five areas were chosen randomly for cell counting under the inverted microscope at magnification of x200. Pretreatment of KCs with hemin ( Fig. 5D ) upregulated HO-1, stabilized MC membranes and decreased migration of DCs to the lower Transwell chamber, compared with KCs pretreated with PBS (Fig. 5B), DMSO (Fig. 5C) or Znpp (Fig. 5E) . Again, there was no difference between the sodium cromoglicate group (Fig. 5F ) and hemin group, confirming that MC degranulation stimulated DC migration.
MC degranulation stimulates DC migration via release of PGE2, CCL19 and CCL21. Stimulation of MC degranulation
may result in the release of cytokines that influence DC migration. The levels cytokines PGE2, CCL19 and CCL21 were measured in supernatants from co-cultures using ELISA (Fig. 6) . Compared with membrane-stabilized MCs, represented by hemin and sodium cromoglicate-treated groups, degranulated MCs produced significantly increased levels of all three cytokines. Due to the fact that increased MC degranulation led to increased DC migration, these cytokines therefore potentially contributed to the changes observed in DC migration.
Discussion
HO-1 catabolizes heme into carbon monoxide, biliverdin and free iron, which helps to protect cells against a variety of potential oxidative stimuli (22) . Recent studies have demonstrated that HO-1 may confer a protective effect in organ transplantation, since HO-1 and its byproducts may protect the allograft from IRI and the immune response following a liver transplant (23) . In rat liver, HO-1 is highly expressed in KCs (24), liver-resident macrophages that have an important role in the acute and chronic responses of the liver to toxic compounds. Our previous study demonstrated that preconditioning donor liver with nodosin perfusion reduces IRI in rats, and this occurs via upregulation of HO-1 that may then prime KCs, which go on to suppress the immune response (25) . The understanding of the role of KCs in IRI and the immune response is incomplete. Upregulation of HO-1 may alleviate IRI and decrease MC degranulation, whereas increased MC degranulation promoted IRI in rat liver (12) . MCs are known to produce various factors responsible for the allergic response, including histamine and inflammatory proteins (26) . These cells function in the innate (27) and adaptive immune system (28). MCs may release cytokines that influence the diseased state, and inhibition of MC degranulation by HO-1 disrupted DC maturation in vitro (29) . This indicates that for MCs to perform their function in the adaptive immune system, DC maturation and migration may be required. DCs reside in an immature state in peripheral blood and tissues until activated by inflammatory cytokines or antigens. Following activation, DCs are transported via the afferent lymphatic system into the draining lymph node before initiating an immune response (30) . DC migration is influenced by CCRs on the cell surface, and CCR7 is the most important receptor in numerous diseases (31) . Pahne-Zeppenfeld et al (32) reported that cervical cancer cells suppress the induction of CCR7 in phenotypically mature DCs, which impairs their migration toward the lymph node that is required for the adaptive immune response. CCR7 and its ligands, CCL19 and CCL21, control a diverse array of migratory events during adaptive immunity (33) . Blocking CCR7 or its ligands was effective in promoting graft survival in animal models of heart or islet allotransplantation (34) . Expression of CCR7 is influenced by PGE2, and PGE2 antagonists downregulate CCR7 expression (35, 36) . Torres et al (37) determined that MC degranulation caused PGE2 release, which inhibited asthma.
Our previous study revealed that the upregulation the HO-1 expression of liver tissue may inhibit MC degranulation and the HO-1 expression in the KC was intracellular. In the present study HO-1 was upregulated in KCs when they were pretreated with hemin, then co-cultured with MC, the MC membranes were stabilized. Co-culturing DCs with membrane-stabilized MCs resulted in downregulation of CCR7 on the surface of DCs. Furthermore, the levels of the cytokines PGE2, CCL9 and CCL21 were decreased in the supernatants of co-cultured DCs. Membrane-stabilized MCs also impaired DC migration. The present study demonstrates a potential mechanism of DC homing in vitro and may explain a possible mechanism that MC degranulation would induce immune rejection. The relevance of this potential mechanism in vivo requires further investigation.
